Related Experiment Video
Updated: Apr 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Antibacterial agents based on the cyclic D,L-alpha-peptide architecture
S Fernandez-Lopez1, H S Kim, E C Choi
1Present address: Departamento de Química Orgánica, Universidad de Santiago de Compostela, 15706 Santiago de Compostela, Spain.
New cyclic peptides show potent antibacterial activity against drug-resistant bacteria. These compounds selectively target bacterial membranes, offering a promising new therapeutic strategy to combat infections and overcome antibiotic resistance.
Area of Science:
- Biochemistry
- Microbiology
- Drug Discovery
Background:
- The rise of antibiotic-resistant bacterial infections necessitates novel therapeutic approaches.
- Existing antibiotics face challenges due to resistance and limited efficacy.
Purpose of the Study:
- To investigate the antibacterial potential of cyclic d,l-alpha-peptides.
- To assess their selectivity towards bacterial membranes versus mammalian cells.
Main Methods:
- Synthesized six- and eight-residue cyclic d,l-alpha-peptides.
- Evaluated membrane permeability and ion potential changes in bacteria.
- Tested efficacy against methicillin-resistant Staphylococcus aureus (MRSA) in a mouse model.
Main Results:
- Cyclic d,l-alpha-peptides demonstrated preferential activity against Gram-positive and Gram-negative bacteria.
- These peptides increased bacterial membrane permeability and collapsed transmembrane ion potentials, leading to rapid cell death.
- High efficacy was observed in treating lethal MRSA infections in mice.
Conclusions:
- Cyclic d,l-alpha-peptides are effective, selective antibacterial agents with potential to combat drug-resistant bacteria.
- Their proteolytic stability and ease of synthesis make them attractive therapeutic candidates.
- These novel peptides complement existing antibiotics and may help mitigate the development of further resistance.
Related Concept Videos
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Bacterial Cell Wall
Peptidoglycan Synthesis
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Inhibitors of Bacterial DNA Synthesis

